Wednesday, July 8, 2026

pharma · Skin Toxicities Associated with Epidermal Growth Factor Receptor Inhibitors · Atopic Dermatitis · HOTH

Hoth Therapeutics

Hoth Therapeutics clinical programs — 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Norwich, GB HQ
12 Employees
Public company Type
HOTH · NYSE Ticker
Company details
Status
Public
HQ
Norwich, GB
Employees
12
Programs
3
Drugs
4
Patents
1
Intelligence · Clinical Programs

Hoth Therapeutics projects

1 ClinicalTrials.gov programs sponsored by Hoth Therapeutics.

Hoth Therapeutics has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. BioLexa- Cohort 1

    Hoth Therapeutics

    Atopic Dermatitis

    phase 1 small molecule completed

    1 trial

Frequently asked questions

How many clinical projects does Hoth Therapeutics have?

1 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.